MicroRNA-21 regulation of the progression of viral myocarditis to dilated cardiomyopathy

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 161-168

  Xu, Hong Fei ^a   Ding, Y U Jie ^b   Zhang, Zhi Xiang ^a   Wang, Z U Feng ^a   Luo, Cheng Liang ^c   Li, Bei X U ^c   Shen, Y I Wen ^c   Tao, L U Yang ^a   Zhao, Z I Qin ^c  

^a SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Dilated cardiomyopathy; microRNA; miRNA 21; SPRY; Viral myocarditis

Indexed keywords

MESSENGER RNA; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; SPROUTY PROTEIN; SPROUTY PROTEIN 1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MEMBRANE PROTEIN; MICRORNA; MIRN21 MICRORNA, MOUSE; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SPRY1 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIOINFORMATICS; CELL INFILTRATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA STABILITY; VIRUS MYOCARDITIS; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; ENTEROVIRUS; GENETICS; HEART MUSCLE; METABOLISM; MIDDLE AGED; MYOCARDITIS; PATHOGENICITY; PATHOLOGY; VIROLOGY; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ANIMALS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENTEROVIRUS B, HUMAN; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDITIS; MYOCARDIUM; PHOSPHOPROTEINS; YOUNG ADULT;

EID: 84901454916     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2205     Document Type: Article

References (38)

1. Richardson P, McKenna W, Bristow M, et al: Report of the 1995 World Health Organization/International Society and Federation of Cardiolgy Task Force on the definition and classification of cardiomyopathies. Circulation 93: 841-842, 1996. (Pubitemid 26074816)
2. Feldman AM and McNamara D: Myocarditis. N Engl Med 343: 1388-1398, 2000.
3. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 99: 1091-1100, 1999.
4. Miyamoto SD, DeBiasi RL and Long CS: Novel therapeutic targets in viral myocarditis. Future Virol 3: 373-381, 2008.
5. Zhao Y, Samal E and Srivastava D: Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-222, 2005.
6. Lin Z, Murtaza I, Wang K, et a1: miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 106: 12103-12108, 2009.
7. Shan ZX, Lin QX, Fu YH, et al: Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun 381: 597-601, 2009.
8. Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS and Amir O: Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail 14: 147-154, 2012.
9. Seto AG and van Rooij E: Circulating microRNAs to identify human heart failure. Eur J Heart Fail 14: 118-119, 2012.
10. Karp X and Ambros V: Developmental biology: encountering microRNAs in cell fate signaling. Science 310: 1288-1289, 2005. (Pubitemid 41698853)
11. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J and Zhang C: Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 87: 431-439, 2010.
12. Cai C, Masumiya H, Weisleder N, et al: MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11: 56-64, 2009.
13. Hacohen N, Kramer S, Sutherland D, Hiromi Y and Krasnow MA: Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92: 253-263, 1998. (Pubitemid 28073048)
14. Minowada G, Jarvis LA, Chi CL, Neubüser A, Sun X, Hacohen N, Krasnow MA and Martin GR: Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development 126: 4465-4475, 1999.
15. Cai C, Masumiya H, Weisleder N, Pan Z, Nishi M, Komazaki S, Takeshima H and Ma J: MG53 regulates membrane budding and exocytosis in muscle cells. J Biol Chem 284: 3314-3322, 2009.
16. Cai C, Weisleder N, Ko JK, Komazaki S, Sunada Y, Nishi M, Takeshima H and Ma J: Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3 and dysferlin. J Biol Chem 284: 15894-15902, 2009.
17. Cao C, Zhang Y, Weisleder N, et al: MG53 Constitutes a primary determinant of cardiac ischemic preconditioning. Circulation 121: 2565-2574, 2010.
18. Thum T, Gross C, Fiedler J, et al: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984, 2008.
19. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G and Kandolf R: Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89: 314-318, 1992.
20. Kandolf R, Selinka H and Klingel K: Pathogenesis of Coxsackievirus B infections. In: Molecular Biology of Picornaviruses. Semler BL and Wimmer E (eds). American Society of Microbiology, Washington, DC, pp 405-413, 2002.
21. Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F, Richter A, Wilke A and Komajda M: Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J 20: 93-102, 1999.
22. McMurray, JJV, Adamopoulos S, Anker SD, et al: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14: 803-869, 2012.
23. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
24. Pang L, Koren G, Wang Z and Nattel S: Tissue-specific expression of two human Ca(v)1.2 isoforms under the control of distinct 5′ flanking regulatory elements. FEBS Lett 546: 349-354, 2003. (Pubitemid 36782438)
25. Luo X, Xiao J, Lin H, Li B, Lu Y, Yang B and Wang Z: Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 212: 358-367, 2007. (Pubitemid 47025625)
26. Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA: Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 98: 9742-9747, 2001. (Pubitemid 32769374)
27. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell 115: 787-798, 2003. (Pubitemid 38058492)
28. Brennecke J, Stark A, Russell RB and Cohen SM: Principles of microRNA-target recognition. PLoS Biol 3: e85, 2005.
29. Cannell IG, Kong YW and Bushell M: How do microRNAs regulate gene expression? Biochem Soc Trans 36: 1224-1231, 2008.
30. Griffiths-Jones S: The microRNA registry. Nucleic Acids Res 32: D109-D111, 2004.
31. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419, 2003. (Pubitemid 37187272)
32. Lund E, Güttinger S, Calado A, Dahlberg JE and Kutay U: Nuclear export of microRNA precursors. Science 303: 95-98, 2004. (Pubitemid 38055779)
33. Khvorova A, Reynolds A and Jayasena SD: Functional siRNAs and miRNAs exhibit strand bias. Cell 115: 209-216, 2003. (Pubitemid 37329584)
34. Xu HF, Li YH, Chen Y and Cheng LB: The expression of dystrophin in human viral myocarditis and dilated cardiomyopathy. Fa Yi Xue Za Zhi 22: 12-14, 2006 (In Chinese).
35. Xu HF; Chen JL; Da XP, Wu KR, Liu GQ, Zhao ZQ and Han XH: Expression of CAR in myocardial of viral myocarditis and dilated cardiomyopathy. Fa Yi Xue Za Zhi 26: 328-331, 2010 (In Chinese).
36. Kawai C: From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99: 1091-1100, 1999.
37. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183, 2001. (Pubitemid 32458157)
38. Heldin CH, Miyazono K and ten Dijke P: TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997. (Pubitemid 28013118)